ICD-10 Code C50.622 | Malignant neoplasm of axillary tail of left male breast Symptoms, Diagnosis, Billing

Malignant neoplasm of axillary tail of left male breast refers to a cancerous tumor located in the axillary tail region of the left breast in males. This condition is clinically significant due to its potential for metastasis and the need for timely diagnosis and treatment. The ICD-10 Code C50.622 facilitates accurate documentation, billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this serious condition.

What is ICD-10 Code C50.622 for Malignant neoplasm of axillary tail of left male breast?

ICD-10 Code C50.622 represents a malignant neoplasm located in the axillary tail of the left male breast. This code is used when documenting cases of breast cancer specifically affecting this anatomical region. It is essential for accurate clinical documentation and billing, particularly when distinguishing this condition from other breast-related malignancies.

ICD-10 Code C50.622 – Clinical Definition and Explanation of Malignant neoplasm of axillary tail of left male breast

Malignant neoplasm of the axillary tail of the left male breast is characterized by the uncontrolled growth of abnormal cells in this specific area. The condition can arise from various risk factors, including genetic predisposition and environmental influences. Early detection and intervention are crucial to improve outcomes.

Key Clinical Features:

• Presence of a palpable mass in the axillary tail region.
• Possible associated lymphadenopathy in the axillary area.
• Symptoms may include pain, swelling, or changes in breast appearance.
• Higher incidence in males with a family history of breast cancer.

ICD-10 Code C50.622 for Malignant neoplasm of axillary tail of left male breast – SOAP Notes & Clinical Use

ICD-10 Code C50.622 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to the malignant neoplasm of the axillary tail of the left male breast. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C50.622 for Malignant neoplasm of axillary tail of left male breast Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C50.622 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of malignant neoplasm in the specified region. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C50.622 – Malignant neoplasm of axillary tail of left male breast

The management of malignant neoplasm of the axillary tail of the left male breast requires prompt medical intervention, often necessitating hospitalization for comprehensive care.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Pain management through analgesics.
• Psychosocial support for emotional well-being.
• Nutritional support to maintain strength during treatment.

Infection Control:

• Standard precautions to prevent infection during treatment.
• Monitoring for signs of infection post-surgery or treatment.

How to Document Symptoms of Malignant neoplasm of axillary tail of left male breast (ICD-10 C50.622) in SOAP Notes

Subjective:

• Patient reports a lump in the left breast's axillary tail.
• Complaints of localized pain and tenderness.
• History of weight loss and fatigue over the past month.
• Family history of breast cancer noted.

Objective:

• Physical examination reveals a firm, irregular mass in the left axillary tail.
• Palpable lymph nodes in the left axilla.
• Imaging studies show a suspicious lesion in the left breast.
• Vital signs stable with no signs of acute distress.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Malignant neoplasm of axillary tail of left male breast (ICD-10 Code C50.622)

Assessment:

• Diagnosis: Malignant neoplasm of axillary tail of left male breast, Stage II.
• ICD-10 Code: C50.622.
• Contributing factors include family history and age.
• Patient presents with significant symptoms requiring intervention.

Plan:

• Refer to oncology for further evaluation and treatment options.
• Consider surgical intervention for tumor removal.
• Initiate chemotherapy based on oncologist's recommendations.
• Schedule follow-up appointments for monitoring and support.

Treatment & Plan Section for ICD-10 Code C50.622 – Malignant neoplasm of axillary tail of left male breast

• Chemotherapy as a first-line treatment option.
• Surgical intervention for tumor excision.
• Radiation therapy may be indicated post-surgery.
• Psychosocial support services for patient and family.

Using ICD-10 Code C50.622 for Malignant neoplasm of axillary tail of left male breast in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and findings in SOAP notes.
• Use C50.622 in all relevant billing scenarios for breast cancer treatment.
• Align treatment plans with clinical guidelines to support billing.
• Document any associated procedures or services for comprehensive coding.

Related ICD-10 Codes Often Used with Malignant neoplasm of axillary tail of left male breast

• C50.621 – Malignant neoplasm of axillary tail of right male breast
• C50.811 – Malignant neoplasm of upper-inner quadrant of left male breast
• C50.812 – Malignant neoplasm of lower-inner quadrant of left male breast

ICD-10 Code C50.622 in Medical Billing and Insurance for Malignant neoplasm of axillary tail of left male breast

ICD-10 Code C50.622 is critical for accurate billing in hospital, ER, or oncology settings, ensuring proper reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings to support the use of C50.622.
• Ensure the code is used in conjunction with appropriate CPT codes for procedures.
• Maintain clear records of treatment plans and patient interactions.
• Review coding guidelines regularly to ensure compliance.

Common CPT Pairings: